Today, prostate cancer treatment involves more than imaging scans and pathology reports. Molecular profiling can provide deeper insight into the biology of a patient’s cancer, helping physicians personalize treatment strategies, identify targeted therapy options, evaluate clinical trial eligibility, and detect inherited mutations that may have implications for family members. This session will explore how molecular testing is helping empower more informed treatment decisions.